Kallikrein 9 antibody (KLK9) (AA 236-250)

Details for Product anti-KLK9 Antibody No. ABIN3043038
Target
Binding Specificity
AA 236-250, C-Term
8
8
7
7
4
2
2
2
1
1
1
Reactivity
Human
45
20
16
Host
Rabbit
46
5
Clonality
Polyclonal
Conjugate
This Kallikrein 9 antibody is un-conjugated
5
4
3
2
2
2
2
1
1
1
1
1
1
1
1
1
1
Application
Western Blotting (WB)
39
24
18
13
9
4
4
4
2
1
1
1
Options
Purpose Rabbit IgG polyclonal antibody for Kallikrein-9(KLK9) detection. Tested with WB in Human.
Immunogen A synthetic peptide corresponding to a sequence at the C-terminus of human Kallikrein 9(236-250aa SVCHYLDWIQEIMEN).
Sequence SVCHYLDWIQ EIMEN
Isotype IgG
Cross-Reactivity (Details) No cross reactivity with other proteins.
Characteristics Rabbit IgG polyclonal antibody for Kallikrein-9(KLK9) detection. Tested with WB in Human.
Gene Name: kallikrein-related peptidase 9
Protein Name: Kallikrein-9
Purification Immunogen affinity purified.
Target
Alternative Name KLK9 (KLK9 Antibody Abstract)
Background KLK9(kallikrein-related peptidase 9) also known as kallikrein 9 or KLK-L3, belongs to the kallikrein subgroup of serine proteases, which have diverse physiologic functions in many tissues. The KLK9 gene contains 5 coding exons and is mapped to 19q13.41. The KLK9 gene is regulated by steroid hormones in a human breast cancer cell line. Yousef et al.(2001) performed a quantitative analysis of KLK9 expression in ovarian cancer. The results indicated thatKLK9 is under steroid hormone regulation in ovarian and breast cancer cell lines. KLK9 is a potential independent favorable prognostic marker for early-stage, low-grade, optimally debulked ovarian cancer patients.

Synonyms: Kallikrein 8 antibody|Kallikrein 9 antibody|Kallikrein L3 antibody|Kallikrein Like 3 antibody|Kallikrein like protein 3 antibody|kallikrein related peptidase 9 antibody|Kallikrein-9 antibody|Kallikrein-like protein 3 antibody|Kallikrein8 antibody|Kallikrein9 antibody|KLK 8 antibody|KLK 9 antibody|KLK L3 antibody|KLK-L3 antibody|KLK8 antibody|KLK9 antibody|KLK9_HUMAN antibody|KLKL 3 antibody|KLKL3 antibody
Pathways Complement System
Application Notes WB: Concentration: 0.1-0.5 μg/mL, Tested Species: Human
Notes: Tested Species: Species with positive results. Predicted Species: Species predicted to be fit for the product based on sequence similarities.
Other applications have not been tested. Optimal dilutions should be determined by end users.
Comment

Antibody can be supported by chemiluminescence kit ABIN921124 in WB.

Restrictions For Research Use only
Format Lyophilized
Reconstitution Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
Concentration 500 μg/mL
Buffer Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg Sodium azide.
Preservative Thimerosal (Merthiolate), Sodium azide
Precaution of Use This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
Handling Advice Avoid repeated freezing and thawing.
Storage 4 °C/-20 °C
Storage Comment At -20°C for one year. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20 °C for a longer time. Avoid repeated freezing and thawing.
Expiry Date 12 months
Images
Image no. 1 for anti-Kallikrein 9 (KLK9) (AA 236-250), (C-Term) antibody (ABIN3043038) Anti-Kallikrein 9 antibody, Western blotting Lane 1: MCF-7 Cell Lysate Lane 2: A431 C...
Image no. 2 for anti-Kallikrein 9 (KLK9) (AA 236-250), (C-Term) antibody (ABIN3043038) Anti-Kallikrein 9 antibody, Western blotting Lane 1: MCF-7 Cell Lysate Lane 2: A431 C...